chrX-49304864-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001098413.4(GAGE10):c.5G>A(p.Ser2Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000324 in 1,205,736 control chromosomes in the GnomAD database, including 1 homozygotes. There are 105 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001098413.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GAGE10 | NM_001098413.4 | c.5G>A | p.Ser2Asn | missense_variant | 2/5 | ENST00000407599.4 | NP_001091883.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GAGE10 | ENST00000407599.4 | c.5G>A | p.Ser2Asn | missense_variant | 2/5 | 5 | NM_001098413.4 | ENSP00000385415.3 |
Frequencies
GnomAD3 genomes AF: 0.000221 AC: 25AN: 113028Hom.: 0 Cov.: 26 AF XY: 0.000114 AC XY: 4AN XY: 35154
GnomAD3 exomes AF: 0.000148 AC: 27AN: 182814Hom.: 0 AF XY: 0.000193 AC XY: 13AN XY: 67368
GnomAD4 exome AF: 0.000335 AC: 366AN: 1092708Hom.: 1 Cov.: 42 AF XY: 0.000281 AC XY: 101AN XY: 360004
GnomAD4 genome AF: 0.000221 AC: 25AN: 113028Hom.: 0 Cov.: 26 AF XY: 0.000114 AC XY: 4AN XY: 35154
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.5G>A (p.S2N) alteration is located in exon 2 (coding exon 1) of the GAGE10 gene. This alteration results from a G to A substitution at nucleotide position 5, causing the serine (S) at amino acid position 2 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at